Resources

Safety and Efectiveness of COVID‐19 Vaccines During Pregnancy: A Living Systematic Review and Meta‐analysis

Pregnant persons are susceptible to significant complications following COVID-19, even death. However, worldwide COVID-19 vaccination coverage during pregnancy remains suboptimal. This study assessed the safety and effectiveness of COVID-19 vaccines administered to pregnant persons and shared this evidence via an interactive online website.

First place in the research award for “Evidence map and interactive real-time meta-analyses to present results of a living systematic review (LSR) of COVID-19 vaccines during pregnancy”.

The First Place in the Research Award was granted for the project titled "Evidence map and interactive real-time meta-analyses to present results of a living systematic review (LSR) of COVID-19 vaccines during pregnancy" at the XX Meeting of the Ibero-American Cochrane Network, held from June 5-7, 2024, in Buenos Aires, Argentina. This accolade highlights significant technological innovation and contributions to public health, addressing the critical issue of COVID-19 with a focus on maternal health.

Safety, effectiveness, and immunogenicity of Chikungunya vaccines in pregnant persons: a living systematic review and meta-analysis.

Mabel Berrueta, Agustin Ciapponi, Agustin Mazzoni, Jamile Ballivian, Ariel Bardach, Juan Sambade, Martin Brizuela, Katharina Stegelman, Edward Parker, Andy Stergachis, Xu Xiong, Flor Munoz, Pierre Buekens

Safety, immunogenicity, and effectiveness of Chikungunya vaccines in newborns, infants, children, and adolescents: a living systematic review and meta-analysis

Mabel Berrueta, Agustin Ciapponi, Agustina Mazzoni, Jamile Ballivian, Ariel Bardach, Juan Manuel Sambade, Martin Brizuela, Katharina Stegelmann, Edward Parker, Andy Stergachis, Xu Xiong, Flor Munoz, Pierre Buekens

Preparing for the next emerging perinatal infectious disease

This special issue of the journal highlights emerging and reemerging pediatric viral diseases. With climate change, mosquito-borne diseases are spreading, from Zika virus (ZIKV) to dengue virus (DENV) and chikungunya virus (CHKV) infections. A global One Health approach is crucial, linking domestic and international efforts and developing solutions through collaborative actions.

The Continuous Textbook of Women’s Medicine Series – Maternal immunization

Professor Asma Khalil - The Royal College of Obstetricians and Gynaecologists, London, UK University College London Hospitals NHS Foundation Trust, London, UK
Professor Flor M Munoz - Baylor College of Medicine, TX, USA Professor Ajoke Sobanjo-ter Meulen - University of Washington, Seattle, WA, USA

Safety, immunogenicity, and effectiveness of COVID-19 vaccines for pregnant persons: A protocol for systematic review and meta analysis

We aim to conduct a living systematic review and meta-analysis based on biweekly searches of medical databases (e.g., MEDLINE, EMBASE, CENTRAL) and clinical trial registries to systematically identify relevant studies of COVID-19 vaccines for pregnant persons.

Data collection systems for active safety surveillance of vaccines during pregnancy in low- and middle-income countries: developing and piloting an assessment tool (VPASS)

We conducted a rapid review of the literature to identify frameworks on population health or post-marketing drug surveillance. Four frameworks that met the eligibility criteria were identified and served to develop an assessment tool capable of evaluating sites that could support active monitoring of vaccine safety during pregnancy.

Safety of COVID-19 vaccines during pregnancy: A systematic review and meta-analysis

A systematic review and meta-analysis to evaluate the safety of COVID-19 vaccines, including their components and technological platforms used in other vaccines during pregnancy and animal studies to complement direct evidence.

Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review

A rapid systematic review to evaluate the safety of COVID-19 vaccines selected by the COVID-19 Vaccines Global Access-Maternal Immunization Working Group in August 2020.